199 related articles for article (PubMed ID: 11964126)
1. Glycoprotein IIb/IIIa antagonists--from bench to practice.
Casserly IP; Topol EJ
Cell Mol Life Sci; 2002 Mar; 59(3):478-500. PubMed ID: 11964126
[TBL] [Abstract][Full Text] [Related]
2. Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions.
Leclerc JR
Crit Care Med; 2002 May; 30(5 Suppl):S332-40. PubMed ID: 12004256
[TBL] [Abstract][Full Text] [Related]
3. Anti-platelet therapy: glycoprotein IIb-IIIa antagonists.
Schneider DJ
Br J Clin Pharmacol; 2011 Oct; 72(4):672-82. PubMed ID: 21906121
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation.
Frelinger AL; Furman MI; Krueger LA; Barnard MR; Michelson AD
Circulation; 2001 Sep; 104(12):1374-9. PubMed ID: 11560852
[TBL] [Abstract][Full Text] [Related]
5. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?
Silva MA; Donovan JL; Gandhi PJ; Volturo GA
Vasc Health Risk Manag; 2006; 2(1):39-48. PubMed ID: 17319468
[TBL] [Abstract][Full Text] [Related]
6. Current issues with glycoprotein IIb-IIIa antagonists.
Schneider DJ
Curr Drug Targets; 2011 Nov; 12(12):1813-20. PubMed ID: 21718238
[TBL] [Abstract][Full Text] [Related]
7. Platelet glycoprotein IIb/IIIa receptor antagonists: current concepts and future directions.
Ferguson JJ; Zaqqa M
Drugs; 1999 Dec; 58(6):965-82. PubMed ID: 10651385
[TBL] [Abstract][Full Text] [Related]
8. Platelet glycoprotein IIb/IIIa receptor antagonists.
Casserly IP; Moliterno DJ
Expert Opin Pharmacother; 2000 Mar; 1(3):419-33. PubMed ID: 11249527
[TBL] [Abstract][Full Text] [Related]
9. [Variations in glycoprotein IIb-IIIa (alphaIIb/beta3-integrin) content in healthy donors. Influence on platelet aggregation activity and efficacy of aspirin action].
Khaspekova SG; Sirotkina OV; Shimanova IuV; Mazurov AV
Biomed Khim; 2008; 54(3):361-71. PubMed ID: 18712091
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of eptifibatide.
Phillips DR; Scarborough RM
Am J Cardiol; 1997 Aug; 80(4A):11B-20B. PubMed ID: 9291241
[TBL] [Abstract][Full Text] [Related]
11. [Use of platelet glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndrome and coronary intervention].
Kakuta T; Kishi Y; Numano F
Nihon Rinsho; 1998 Oct; 56(10):2630-4. PubMed ID: 9796330
[TBL] [Abstract][Full Text] [Related]
12. Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective.
Dyke CM
Am Heart J; 1999 Oct; 138(4 Pt 2):307-16. PubMed ID: 10502236
[TBL] [Abstract][Full Text] [Related]
13. GPIIb/IIIa inhibitors: from bench to bedside and back to bench again.
Armstrong PC; Peter K
Thromb Haemost; 2012 May; 107(5):808-14. PubMed ID: 22370973
[TBL] [Abstract][Full Text] [Related]
14. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
[TBL] [Abstract][Full Text] [Related]
15. Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease.
Vorchheimer DA; Badimon JJ; Fuster V
JAMA; 1999 Apr; 281(15):1407-14. PubMed ID: 10217057
[TBL] [Abstract][Full Text] [Related]
16. Effects Of Glycoprotein IIb/IIIa Antagonists: Anti Platelet Aggregation And Beyond.
Giordano A; Musumeci G; D'Angelillo A; Rossini R; Zoccai GB; Messina S; Coscioni E; Romano S; Romano MF
Curr Drug Metab; 2016; 17(2):194-203. PubMed ID: 26652157
[TBL] [Abstract][Full Text] [Related]
17. Learning from the recently completed oral glycoprotein IIb/IIIa receptor antagonist trials.
Cannon CP
Clin Cardiol; 2000 Nov; 23 Suppl 6(Suppl 6):VI-14-7. PubMed ID: 11129681
[TBL] [Abstract][Full Text] [Related]
18. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Bhatt DL; Topol EJ
JAMA; 2000 Sep; 284(12):1549-58. PubMed ID: 11000650
[TBL] [Abstract][Full Text] [Related]
19. Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease.
Berkowitz SD
Haemostasis; 2000; 30 Suppl 3():27-43. PubMed ID: 11182626
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein IIb/IIIa receptor antagonists in the management of cardiovascular diseases.
Chong PH
Am J Health Syst Pharm; 1998 Nov; 55(22):2363-86. PubMed ID: 9825033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
